AIRS - AirSculpt Technologies gains after setting guidance ahead of consensus

The shares of AirSculpt Technologies (AIRS +7.2%) have recorded a double-digit gain in percentage terms after reporting better-than-anticipated revenue for Q3 2021 and setting its 2021 outlook slightly ahead of expectations. The healthcare service provider focused on fat removal procedures saw its quarterly revenue rise ~94% YoY to $34.7M as case numbers increased by ~60.4% YoY to 2,743 cases. While the adjusted EBITDA more than doubled with ~127.2% YoY growth to $12.1M, net income climbed ~179.3% YoY to $8.1M. “Our revenues continue to be fueled by both volume increases and higher revenue per case compared to prior periods,” Ron Zelhof, Chief Operating Officer, remarked. For 2021, the company expects its revenue and adjusted EBITDA to reach $130M and $46M, respectively. Meanwhile, the consensus estimates for AirSculpt (NASDAQ:AIRS) indicate ~$129.8M in revenue for this year.

For further details see:

AirSculpt Technologies gains after setting guidance ahead of consensus